Fig. 5

a Increased serum Semaphorin 4D (Sema4D) levels correlated with higher ISS stage in multiple myeloma patients (p < 0.001). b Serum Semaphorin 4D (Sema4D) levels in patients with osteolyses vs. those without bone disease in plain radiographs (p = 0.07)